![The Pharmacokinetics, Metabolism, and Clearance Mechanisms of Tofacitinib, a Janus Kinase Inhibitor, in Humans | Drug Metabolism & Disposition The Pharmacokinetics, Metabolism, and Clearance Mechanisms of Tofacitinib, a Janus Kinase Inhibitor, in Humans | Drug Metabolism & Disposition](https://dmd.aspetjournals.org/content/dmd/42/4/759/F7.large.jpg)
The Pharmacokinetics, Metabolism, and Clearance Mechanisms of Tofacitinib, a Janus Kinase Inhibitor, in Humans | Drug Metabolism & Disposition
![Inhibition of pSTAT1 by tofacitinib accounts for the early improvement of experimental chronic synovitis | Journal of Inflammation | Full Text Inhibition of pSTAT1 by tofacitinib accounts for the early improvement of experimental chronic synovitis | Journal of Inflammation | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12950-019-0206-2/MediaObjects/12950_2019_206_Fig1_HTML.png)
Inhibition of pSTAT1 by tofacitinib accounts for the early improvement of experimental chronic synovitis | Journal of Inflammation | Full Text
![Pharmacokinetic boosting to enable a once-daily reduced dose of tofacitinib in patients with rheumatoid arthritis and psoriatic arthritis (the PRACTICAL study) - Céleste J.T. van der Togt, Lise M. Verhoef, Bart J.F. Pharmacokinetic boosting to enable a once-daily reduced dose of tofacitinib in patients with rheumatoid arthritis and psoriatic arthritis (the PRACTICAL study) - Céleste J.T. van der Togt, Lise M. Verhoef, Bart J.F.](https://journals.sagepub.com/cms/10.1177/1759720X221142277/asset/images/large/10.1177_1759720x221142277-fig3.jpeg)
Pharmacokinetic boosting to enable a once-daily reduced dose of tofacitinib in patients with rheumatoid arthritis and psoriatic arthritis (the PRACTICAL study) - Céleste J.T. van der Togt, Lise M. Verhoef, Bart J.F.
![Tofacitinib-Induced Modulation of Intestinal Adaptive and Innate Immunity and Factors Driving Cellular and Systemic Pharmacokinetics - ScienceDirect Tofacitinib-Induced Modulation of Intestinal Adaptive and Innate Immunity and Factors Driving Cellular and Systemic Pharmacokinetics - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2352345X21001922-fx1.jpg)
Tofacitinib-Induced Modulation of Intestinal Adaptive and Innate Immunity and Factors Driving Cellular and Systemic Pharmacokinetics - ScienceDirect
![Developing a Biorelevant Dissolution Method for an Extrudable Core System (ECS) Osmotic Tablet | SpringerLink Developing a Biorelevant Dissolution Method for an Extrudable Core System (ECS) Osmotic Tablet | SpringerLink](https://media.springernature.com/m685/springer-static/image/art%3A10.1208%2Fs12249-021-02110-x/MediaObjects/12249_2021_2110_Fig6_HTML.png)
Developing a Biorelevant Dissolution Method for an Extrudable Core System (ECS) Osmotic Tablet | SpringerLink
![PDF] Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata. | Semantic Scholar PDF] Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/fc5f0cad762661757482587b8188f86c9c1a4db2/5-Table3-1.png)
PDF] Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata. | Semantic Scholar
![In vitro inhibitory effect of released tofacitinib citrate on CCL-2... | Download Scientific Diagram In vitro inhibitory effect of released tofacitinib citrate on CCL-2... | Download Scientific Diagram](https://www.researchgate.net/profile/Andrea-Heinz/publication/366262899/figure/fig6/AS:11431281112130772@1673359528001/In-vitro-inhibitory-effect-of-released-tofacitinib-citrate-on-CCL-2-production-in_Q320.jpg)
In vitro inhibitory effect of released tofacitinib citrate on CCL-2... | Download Scientific Diagram
![Pharmaceutics | Free Full-Text | Tofacitinib Loaded Squalenyl Nanoparticles for Targeted Follicular Delivery in Inflammatory Skin Diseases Pharmaceutics | Free Full-Text | Tofacitinib Loaded Squalenyl Nanoparticles for Targeted Follicular Delivery in Inflammatory Skin Diseases](https://pub.mdpi-res.com/pharmaceutics/pharmaceutics-12-01131/article_deploy/html/images/pharmaceutics-12-01131-ag-550.jpg?1606206264)
Pharmaceutics | Free Full-Text | Tofacitinib Loaded Squalenyl Nanoparticles for Targeted Follicular Delivery in Inflammatory Skin Diseases
![Tofacitinib-Induced Modulation of Intestinal Adaptive and Innate Immunity and Factors Driving Cellular and Systemic Pharmacokinetics - ScienceDirect Tofacitinib-Induced Modulation of Intestinal Adaptive and Innate Immunity and Factors Driving Cellular and Systemic Pharmacokinetics - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2352345X21001922-gr8.jpg)
Tofacitinib-Induced Modulation of Intestinal Adaptive and Innate Immunity and Factors Driving Cellular and Systemic Pharmacokinetics - ScienceDirect
![Repigmentation in vitiligo using the Janus kinase inhibitor tofacitinib may require concomitant light exposure - ScienceDirect Repigmentation in vitiligo using the Janus kinase inhibitor tofacitinib may require concomitant light exposure - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0190962217317991-gr3.jpg)